Characterizing the cross-sectional approach to Ovarian cancer: Genetic testing of BRCA - CHARLOTTE

Inclusion Criteria

• Inclusion Criteria:
• For registration to this study, all of the following criteria should be satisfied:
• 1. The subject can attach the signature to the Informed Consent Form (ICF), besides having his/her intention to put the signature.
• 2. Female Japanese at more than 20 years of age
• 3. The newly diagnosed patients whose epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer is histologically confirmed as FIGO from the subject to obtain their utmost understandings. Limited to histopathological diagnosis based on resected tumor specimens (except the cytodiagnosis by ascites paracentesis).
• 4. The histopathological specimens can be submitted to the central pathological judgment.
• 5. Within 60 days after diagnosis of epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer, the patient’s written consent has been obtained.
• Exclusion Criteria:
• -The subjects who coincide any of the following exclusion criteria are designated to be ineligible:
• 1. In case of the subjects who are diagnosed to have acute or chronic physical or severe mental diseases except cancer, and about whom the attending responsible physician makes judgement to say that participation of these subjects would possibly increase the risks or would probably disturb the interpretation of the study results.
• 2. In case of the subjects whose registration for the study is judged by the attending responsible physician as inappropriate.